drugset / Trial / NCT02782754

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

NCT02782754 ↗

Phase 2 Unknown 40 enrolled Samsung Medical Center
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the outcome of intracranial germinoma treated with chemotherapy plus reduced radiotherapy.

Timeline

Start
2013-01
Primary completion
2017-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Bleomycin Unknown — —
Subject Carboplatin Small molecule — —
Subject Cyclophosphamide Other / unclassified — —
Subject Etoposide Small molecule — —